Novel Purification, Separation, and Recovery Technologies

Description

CSL is always looking for novel ways to continually improve its manufacturing effectiveness, therefore we seek purification ideas and technologies that can improve yield, reduce cost, and lessen our impact on the environment.

Background

Our three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapies all use methods to purify protein or viral based targets. Being able to incorporate novel purification, separation, and recovery technologies into these purification processes allows CSL to rapidly develop our future innovative therapies and consistently deliver our current therapeutic portfolio to our patients.

Key Success Criteria

High Yielding
Selective
Rapid
Scalable
Potentially Adaptable to Continuous Processing
Minimal Capital / Utility Needs
Environmentally Friendly

Preferred Collaboration types

CSL and its affiliates are open to a range of collaboration types in this area.